Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity

Journal of Thrombosis and Thrombolysis

Volumn 26, Issue 1, 2008, Pages 31-34

  Irani Hakime, Noha A ^a   Stephan, Farid ^a   Kreidy, Raghid ^a   Jureidini, Isabelle ^a   Almawi, Wassim Y ^b  

^a St Georges University Hospital   (Lebanon)

^b ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Factor V Leiden; Livedoid vasculopathy; MTHFR C677T; Prothrombin G20210A

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ANALGESIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; CYANOCOBALAMIN; DAPSONE; FOLIC ACID; HYDROXYCHLOROQUINE; PREDNISONE; PROTHROMBIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DRUG TREATMENT FAILURE; FEMALE; HEALING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; INFLAMMATORY INFILTRATE; LEG THROMBOSIS; LIVEDOID VASCULOPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY;

ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; BLOOD COAGULATION; DRUG THERAPY, COMBINATION; FACTOR V; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; LIVEDO RETICULARIS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTHROMBIN; TREATMENT OUTCOME;

EID: 48449098780     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0214-1     Document Type: Article

References (24)

1. Schroeter AL, Diaz Perez JL, Winkelmann RK (1975) Livedo vasculitis (the vasculitis of atrophie blanche): Immunohistopathologic study. Arch Dermatol 111:188-193
2. Marzano AV, Vanotti M, Alessi E (2003) Widespread livedoid vasculopathy. Acta Derm Venereol 83:457-460
3. Bard JW, Winkelmann RK (1967) Livedo vasculitis: Segmental hyalinizing vasculitis of the dermis. Arch Dermatol 96:489-499
4. Jorizzo JL (1998) Livedoid vasculopathy: What is it? Arch Dermatol 134:491-493
5. Mimouni D, Ng PP, Rencic A et al (2003) Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 148:789-794
6. Maessen-Visch MB, Koedam MI, Hamulyák K, Neumann HA (1999) Atrophie blanche. Int J Dermatol 38:161-172
7. Hairston BR, Davis MD, Pittelkow MR, Ahmed I (2006) Livedoid vasculopathy: Further evidence for procoagulant pathogenesis. Arch Dermatol 142:1413-1418
8. Biedermann T, Flaig MJ, Sander CA (2000) Livedoid vasculopathy in a patient with factor V mutation (Leiden). J Cutan Pathol 27:410-412
9. Calamia KT, Balabanova M, Perniciaro C, Walsh JS (2002) Livedo (livedoid) vasculitis and the factor V Leiden mutation: Additional evidence for abnormal coagulation. J Am Acad Dermatol 46:133-137
10. Anavekar NS, Kelly R (2007) Heterozygous prothrombin gene mutation associated with livedoid vasculopathy. Australas J Dermatol 48:120-123
11. Gibson GE, Li H, Pittelkow MR (1999) Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol 40:279-281
12. Cardoso R, Goncalo M, Tellechea O et al (2007) Livedoid vasculopathy and hypercoagulability in a patient with primary Sjogren's syndrome. Int J Dermatol 46:431-434
13. Deng A, Gocke CD, Hess J et al (2006) Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Arch Dermatol 142:1466-1469
14. Boyvat A, Kundakçi N, Babikir MO, Gürgey E (2000) Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 143:840-842
15. Meiss F, Marsch WC, Fischer M (2006) Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. Eur J Dermatol 16:159-162
16. Acland KM, Darvay A, Wakelin SH, Russell-Jones R (1999) Livedoid vasculitis: A manifestation of the antiphospholipid syndrome? Br J Dermatol 140:131-135
17. Grasland A, Crickx B, Blanc M, Pouchot J, Vinceneux P (2000) Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies. Ann Med Interne (Paris) 151:408-410
18. Papi M, Didona B, De Pita O et al (1998) Livedo vasculopathy vs. small vessel cutaneous vasculitis: Cytokine and platelet P-selectin studies. Arch Dermatol 134:447-452
19. Browning CE, Callen JP (2006) Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 142:75-78
20. Lewerenz V, Burchardt T, Büchau A, Ruzicka T, Megahed M (2004) Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome. Hautarzt 55:379-381
21. Hairston BR, Davis MD, Gibson LE, Drage LA (2003) Treatment of livedoid vasculopathy with low-molecular-weight heparin: Report of 2 cases. Arch Dermatol 139:987-990
22. Klein KL, Pittelkow MR (1992) Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 67:923-933
23. Pitarch G, Rodriguez-Serna M, Torrijos A, Oliver V, Fortea JM (2005) Treatment of livedoid vasculopathy with short-cycle intravenous immunoglobulins. Acta Derm Venereol 85:374-375
24. Magy N, Algros MP, Racadot E et al (2002) Liveoid vasculopathy with combined thrombophilia: Efficacy of iloprost. Rev Med Interne 23:554-557